Share this page

January 16, 2024

EPS Corporation was awarded as one of the Top 10 Companies of “Regenerative Medicine Solutions Providers in APAC 2024”

EPS Corporation has been named one of the top 10 companies in the Asia-Pacific region as a frontrunner in providing regenerative medicine solutions and influencing the market in "Regenerative Medicine Solutions Providers in APAC 2024" by Medtech Outlook, a global industry publication.

Medtech Outlook remarked EPS Corporation as one of the few CROs in Japan that can provide comprehensive support for the entire lifecycle of regenerative medicine products.

EPS Corporation will continue to provide end-to-end solutions in the development of pharmaceuticals, medical devices and regenerative medicine products. Furthermore, we will respond flexibly to regulatory requirements, and address proactively to new modalities.

Link to article:
https://www.medicaltechoutlook.com/eps-corporation